Busy. Please wait.

show password
Forgot Password?

Don't have an account?  Sign up 

Username is available taken
show password


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
We do not share your email address with others. It is only used to allow you to reset your password. For details read our Privacy Policy and Terms of Service.

Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.

Remove ads
Don't know
remaining cards
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

"Know" box contains:
Time elapsed:
restart all cards

Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

Hypertension Drugs

Mechanism of action for the major categories of antihypertensives

DrugMechanism of Action
ACE inhibitors (captopril, enalapril) Inhibition of ACE leads to reduced angiotensin II (vasodilation) and aldosterone (reduced Na+ retention) levels and increased bradykinin (--> vasodilation) levels.
Angiotensin antagonists (losartan and EXP3174) Inhibition of angiotensin II receptor (--> vasodilation)
Ca++ antagonists (verapamil, diltiazem) Block Ca++ channels. Decreased intracellular Ca++ leads to reduced contractility and vasodilatation.
α1-antagonists (prazosin, doxazocin) Inhibition of α1-mediated vasoconstriction reduces peripheral resistance and venous pressure. Also improves lipid profile to decrease risk of CAD.
Sodium nitroprusside Decomposes to NO, which activate guanylyl cyclase, thus increasing cGMP levels, and causing vasodilatation
Thiazide diuretics (hydrochlorothiazide, polythiazide) Reduction of blood volume/indirect vasodilatation
Centrally acting drugs (clonidine, α-methyldopa) α2-agonists. False transmitter activates central inhibitory neurons, causing inhibition of NA release and vasodilatation.
β-antagonists (nonselective - propranolol, selective - atenolol) Block β1-receptors in heart, causing decreased rate, systolic BP, cardiac contractility, and myocardial O2 demand. Work in heart, kidney (RAS), and CNS
Created by: golfspy